Role of Dok-1 and Dok-2 in Leukemia Suppression

@article{Niki2004RoleOD,
  title={Role of Dok-1 and Dok-2 in Leukemia Suppression},
  author={Masaru Niki and Antonio Di Cristofano and Mingming Zhao and Hiroaki Honda and Hisamaru Hirai and Linda Van Aelst and Carlos Cordon-Cardo and Pier Paolo Pandolfi},
  journal={The Journal of Experimental Medicine},
  year={2004},
  volume={200},
  pages={1689 - 1695}
}
Chronic myelogenous leukemia (CML) is characterized by the presence of the chimeric p210bcr/abl oncoprotein that shows elevated and constitutive protein tyrosine kinase activity relative to the normal c-abl tyrosine kinase. Although several p210bcr/abl substrates have been identified, their relevance in the pathogenesis of the disease is unclear. We have identified a family of proteins, Dok (downstream of tyrosine kinase), coexpressed in hematopoietic progenitor cells. Members of this family… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Chronic myelogenous leuke

  • N. Carpino, D. Wisniewski, +4 authors B. Clarkson
  • Hematology ( Am Soc Hematol Educ Program )
  • 2001
1 Excerpt

quired loss of p 53 induces blastic transformation in p 210 bcr / abl - expressing hematopoietic cells : a transgenic study for blast crisis of human CML

  • A. Di Cristofano, C. Cordon-Cardo
  • Blood .
  • 2001

Similar Papers

Loading similar papers…